The government has OK'd a new drug for gout - the first in 40 years for the painful condition.
Uloric is designed to lower levels of uric acid in the bloodstream. it is a xanthine oxidase inhibitor.
Gout is a form of inflammatory arthritis that often affects one joint - usually the big toe.
However, it can affect a variety of joints in the body.
Uloric was studied on clinical trials involving more than 4,000 patients, some taking the drug for up to 5 years.
The most commonly reported adverse reactions were liver function abnormalities, nausea, joint pain, and rash.
About 5 million americans suffer from gout, and that number is growing.
CLICK HERE to follow Action News on Twitter
CLICK HERE to get Action News on your website
CLICK HERE to find Action News on Facebook
